Skip to main content
Premium Trial:

Request an Annual Quote

Helen Torley

Quest Diagnostics announced that Helen Torley was elected to serve as a director during the company's 2018 annual meeting of stockholders, expanding the board of directors to 10 members. Torley had been president, CEO and director of Halozyme Therapeutics since 2014. She previously served as executive vice president and chief commercial officer for Onyx Pharmaceuticals, as vice president and general manager for Amgen's US bone health and nephrology business, and in various senior management positions at Bristol-Myers Sqibb and Sandoz/Novartis. She was formerly in medical practice as a senior registrar in rheumatology at the Royal Infirmary in Glascow, Scotland.